2022-07-012023-06-302023-06-30false11395445DATA HEALTH INTELLIGENT LIMITED2023-10-1162020iso4217:GBPxbrli:pure113954452022-07-01113954452023-06-30113954452022-07-012023-06-30113954452021-07-01113954452022-06-30113954452021-07-012022-06-3011395445bus:SmallEntities2022-07-012023-06-3011395445bus:AuditExempt-NoAccountantsReport2022-07-012023-06-3011395445bus:FullAccounts2022-07-012023-06-3011395445bus:PrivateLimitedCompanyLtd2022-07-012023-06-3011395445core:WithinOneYear2023-06-3011395445core:AfterOneYear2023-06-3011395445core:WithinOneYear2022-06-3011395445core:AfterOneYear2022-06-3011395445core:ShareCapital2023-06-3011395445core:SharePremium2023-06-3011395445core:RevaluationReserve2023-06-3011395445core:OtherReservesSubtotal2023-06-3011395445core:RetainedEarningsAccumulatedLosses2023-06-3011395445core:ShareCapital2022-06-3011395445core:SharePremium2022-06-3011395445core:RevaluationReserve2022-06-3011395445core:OtherReservesSubtotal2022-06-3011395445core:RetainedEarningsAccumulatedLosses2022-06-3011395445core:LandBuildings2023-06-3011395445core:PlantMachinery2023-06-3011395445core:Vehicles2023-06-3011395445core:FurnitureFittings2023-06-3011395445core:OfficeEquipment2023-06-3011395445core:NetGoodwill2023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2023-06-3011395445core:ListedExchangeTraded2023-06-3011395445core:UnlistedNon-exchangeTraded2023-06-3011395445core:LandBuildings2022-06-3011395445core:PlantMachinery2022-06-3011395445core:Vehicles2022-06-3011395445core:FurnitureFittings2022-06-3011395445core:OfficeEquipment2022-06-3011395445core:NetGoodwill2022-06-3011395445core:IntangibleAssetsOtherThanGoodwill2022-06-3011395445core:ListedExchangeTraded2022-06-3011395445core:UnlistedNon-exchangeTraded2022-06-3011395445core:LandBuildings2022-07-012023-06-3011395445core:PlantMachinery2022-07-012023-06-3011395445core:Vehicles2022-07-012023-06-3011395445core:FurnitureFittings2022-07-012023-06-3011395445core:OfficeEquipment2022-07-012023-06-3011395445core:NetGoodwill2022-07-012023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3011395445core:ListedExchangeTraded2022-07-012023-06-3011395445core:UnlistedNon-exchangeTraded2022-07-012023-06-3011395445core:MoreThanFiveYears2022-07-012023-06-3011395445core:Non-currentFinancialInstruments2023-06-3011395445core:Non-currentFinancialInstruments2022-06-3011395445dpl:CostSales2022-07-012023-06-3011395445dpl:DistributionCosts2022-07-012023-06-3011395445dpl:AdministrativeExpenses2022-07-012023-06-3011395445core:LandBuildings2022-07-012023-06-3011395445core:PlantMachinery2022-07-012023-06-3011395445core:Vehicles2022-07-012023-06-3011395445core:FurnitureFittings2022-07-012023-06-3011395445core:OfficeEquipment2022-07-012023-06-3011395445core:NetGoodwill2022-07-012023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3011395445dpl:GroupUndertakings2022-07-012023-06-3011395445dpl:ParticipatingInterests2022-07-012023-06-3011395445dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3011395445core:ListedExchangeTraded2022-07-012023-06-3011395445dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3011395445core:UnlistedNon-exchangeTraded2022-07-012023-06-3011395445dpl:CostSales2021-07-012022-06-3011395445dpl:DistributionCosts2021-07-012022-06-3011395445dpl:AdministrativeExpenses2021-07-012022-06-3011395445core:LandBuildings2021-07-012022-06-3011395445core:PlantMachinery2021-07-012022-06-3011395445core:Vehicles2021-07-012022-06-3011395445core:FurnitureFittings2021-07-012022-06-3011395445core:OfficeEquipment2021-07-012022-06-3011395445core:NetGoodwill2021-07-012022-06-3011395445core:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3011395445dpl:GroupUndertakings2021-07-012022-06-3011395445dpl:ParticipatingInterests2021-07-012022-06-3011395445dpl:GroupUndertakingscore:ListedExchangeTraded2021-07-012022-06-3011395445core:ListedExchangeTraded2021-07-012022-06-3011395445dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-07-012022-06-3011395445core:UnlistedNon-exchangeTraded2021-07-012022-06-3011395445core:NetGoodwill2023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2023-06-3011395445core:LandBuildings2023-06-3011395445core:PlantMachinery2023-06-3011395445core:Vehicles2023-06-3011395445core:FurnitureFittings2023-06-3011395445core:OfficeEquipment2023-06-3011395445core:AfterOneYear2023-06-3011395445core:WithinOneYear2023-06-3011395445core:ListedExchangeTraded2023-06-3011395445core:UnlistedNon-exchangeTraded2023-06-3011395445core:ShareCapital2023-06-3011395445core:SharePremium2023-06-3011395445core:RevaluationReserve2023-06-3011395445core:OtherReservesSubtotal2023-06-3011395445core:RetainedEarningsAccumulatedLosses2023-06-3011395445core:NetGoodwill2022-06-3011395445core:IntangibleAssetsOtherThanGoodwill2022-06-3011395445core:LandBuildings2022-06-3011395445core:PlantMachinery2022-06-3011395445core:Vehicles2022-06-3011395445core:FurnitureFittings2022-06-3011395445core:OfficeEquipment2022-06-3011395445core:AfterOneYear2022-06-3011395445core:WithinOneYear2022-06-3011395445core:ListedExchangeTraded2022-06-3011395445core:UnlistedNon-exchangeTraded2022-06-3011395445core:ShareCapital2022-06-3011395445core:SharePremium2022-06-3011395445core:RevaluationReserve2022-06-3011395445core:OtherReservesSubtotal2022-06-3011395445core:RetainedEarningsAccumulatedLosses2022-06-3011395445core:NetGoodwill2021-07-0111395445core:IntangibleAssetsOtherThanGoodwill2021-07-0111395445core:LandBuildings2021-07-0111395445core:PlantMachinery2021-07-0111395445core:Vehicles2021-07-0111395445core:FurnitureFittings2021-07-0111395445core:OfficeEquipment2021-07-0111395445core:AfterOneYear2021-07-0111395445core:WithinOneYear2021-07-0111395445core:ListedExchangeTraded2021-07-0111395445core:UnlistedNon-exchangeTraded2021-07-0111395445core:ShareCapital2021-07-0111395445core:SharePremium2021-07-0111395445core:RevaluationReserve2021-07-0111395445core:OtherReservesSubtotal2021-07-0111395445core:RetainedEarningsAccumulatedLosses2021-07-0111395445core:AfterOneYear2022-07-012023-06-3011395445core:WithinOneYear2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:CostValuation2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3011395445core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3011395445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:CostValuation2022-06-3011395445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-3011395445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-3011395445bus:Director12022-07-012023-06-30113954451bus:Director12022-07-01113954451bus:Director12022-07-012023-06-30113954451bus:Director12023-06-30113954452022-07-01113954452022-07-012023-06-30113954452023-06-30

DATA HEALTH INTELLIGENT LIMITED

Registered Number
11395445
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2023

DATA HEALTH INTELLIGENT LIMITED
Company Information
for the year from 1 July 2022 to 30 June 2023

Director

XU, Fenglian, Dr

Registered Address

Unit C Anchor House School Lane
Chandlers Ford
Eastleigh
SO53 4DY

Registered Number

11395445 (England and Wales)
DATA HEALTH INTELLIGENT LIMITED
Balance Sheet as at
30 June 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets53,3051,372
3,3051,372
Current assets
Debtors9375,797
Cash at bank and on hand4,4031,304
5,3407,101
Creditors amounts falling due within one year8(28,772)(15,465)
Net current assets (liabilities)(23,432)(8,364)
Total assets less current liabilities(20,127)(6,992)
Net assets(20,127)(6,992)
Capital and reserves
Called up share capital1,0001,000
Profit and loss account(21,127)(7,992)
Shareholders' funds(20,127)(6,992)
The financial statements were approved and authorised for issue by the Director on 11 October 2023, and are signed on its behalf by:
XU, Fenglian, Dr
Director
Registered Company No. 11395445
DATA HEALTH INTELLIGENT LIMITED
Notes to the Financial Statements
for the year ended 30 June 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Revenue recognition policy
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Going concern
Assurances have been obtained from the directors that the company will continue to operate in the foreseeable future and will be able to meets its liabilities as and when they fall due.
4.Employee information

20232022
Average number of employees during the year00
5.Property, plant and equipment

Office Equipment

Total

££
Cost or valuation
At 01 July 222,7462,746
Additions2,8572,857
At 30 June 235,6035,603
Depreciation and impairment
At 01 July 221,3741,374
Charge for year924924
At 30 June 232,2982,298
Net book value
At 30 June 233,3053,305
At 30 June 221,3721,372
6.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
XU, Fenglian, Dr(13,876)1,50815,579(27,947)
(13,876)1,50815,579(27,947)
7.Debtors within one year

2023

2022

££
Other debtors9375,797
Total9375,797
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
8.Creditors within one year

2023

2022

££
Trade creditors / trade payables10744
Amounts owed to related parties27,94713,876
Accrued liabilities and deferred income815845
Total28,77215,465
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.